Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 6982 | 1344 | 46.9 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | LIVIN | Author keyword | 100 | 74% | 5% | 73 |
| 2 | XIAP | Author keyword | 92 | 40% | 14% | 183 |
| 3 | SMAC MIMETICS | Author keyword | 69 | 93% | 2% | 26 |
| 4 | SMAC | Author keyword | 68 | 54% | 7% | 88 |
| 5 | XAF1 | Author keyword | 38 | 76% | 2% | 26 |
| 6 | SMAC DIABLO | Author keyword | 36 | 51% | 4% | 50 |
| 7 | IAP | Author keyword | 21 | 23% | 6% | 78 |
| 8 | DIABLO | Author keyword | 18 | 65% | 1% | 17 |
| 9 | SMAC MIMETIC | Author keyword | 15 | 62% | 1% | 16 |
| 10 | CIAP2 | Author keyword | 14 | 55% | 1% | 17 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | LIVIN | 100 | 74% | 5% | 73 | Search LIVIN | Search LIVIN |
| 2 | XIAP | 92 | 40% | 14% | 183 | Search XIAP | Search XIAP |
| 3 | SMAC MIMETICS | 69 | 93% | 2% | 26 | Search SMAC+MIMETICS | Search SMAC+MIMETICS |
| 4 | SMAC | 68 | 54% | 7% | 88 | Search SMAC | Search SMAC |
| 5 | XAF1 | 38 | 76% | 2% | 26 | Search XAF1 | Search XAF1 |
| 6 | SMAC DIABLO | 36 | 51% | 4% | 50 | Search SMAC+DIABLO | Search SMAC+DIABLO |
| 7 | IAP | 21 | 23% | 6% | 78 | Search IAP | Search IAP |
| 8 | DIABLO | 18 | 65% | 1% | 17 | Search DIABLO | Search DIABLO |
| 9 | SMAC MIMETIC | 15 | 62% | 1% | 16 | Search SMAC+MIMETIC | Search SMAC+MIMETIC |
| 10 | CIAP2 | 14 | 55% | 1% | 17 | Search CIAP2 | Search CIAP2 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | X LINKED INHIBITOR | 180 | 41% | 25% | 338 |
| 2 | XIAP | 178 | 51% | 19% | 250 |
| 3 | SMAC DIABLO | 170 | 61% | 14% | 182 |
| 4 | ALPHA DEPENDENT APOPTOSIS | 162 | 58% | 14% | 187 |
| 5 | ML IAP | 114 | 87% | 4% | 55 |
| 6 | IAP | 110 | 48% | 13% | 168 |
| 7 | MELANOMA INHIBITOR | 81 | 96% | 2% | 25 |
| 8 | IAP PROTEINS | 78 | 58% | 7% | 89 |
| 9 | SMAC | 72 | 70% | 4% | 60 |
| 10 | IAPS | 58 | 58% | 5% | 66 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Targeting IAP proteins for therapeutic intervention in cancer | 2012 | 161 | 223 | 74% |
| IAPs: from caspase inhibitors to modulators of NF-kappa B, inflammation and cancer | 2010 | 281 | 168 | 44% |
| Smac mimetics as IAP antagonists | 2015 | 1 | 55 | 78% |
| IAPs: What's in a name? | 2008 | 252 | 108 | 52% |
| Small-molecule SMAC mimetics as new cancer therapeutics | 2014 | 9 | 141 | 70% |
| IAP-targeted therapies for cancer | 2008 | 238 | 242 | 53% |
| The inhibitors of apoptosis (IAPs) as cancer targets | 2007 | 284 | 214 | 48% |
| IAP proteins: Blocking the road to death's door | 2002 | 1121 | 148 | 38% |
| XIAP as a ubiquitin ligase in cellular signaling | 2010 | 61 | 75 | 71% |
| Targeting XIAP for the treatment of malignancy | 2006 | 182 | 73 | 74% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | EXPT CANC PEDIAT | 11 | 30% | 2.2% | 30 |
| 2 | AEGERA ONCOL INC | 9 | 83% | 0.4% | 5 |
| 3 | SOLANGE GAUTHIER KARSH MOL GENET | 6 | 45% | 0.7% | 10 |
| 4 | EARLY ADME | 2 | 67% | 0.1% | 2 |
| 5 | PROGRAM OPTOSIS CELL DEATH | 2 | 12% | 1.3% | 17 |
| 6 | EARLY DISCOVERY BIOCHEM | 2 | 13% | 1.0% | 13 |
| 7 | FDN MATARELLI | 2 | 22% | 0.4% | 6 |
| 8 | SOLANGE GAUTHIER KARSH | 1 | 31% | 0.3% | 4 |
| 9 | CELL DEATH | 1 | 19% | 0.5% | 7 |
| 10 | DIPARTIMENTO ONCOL SPERIMENTALE MED MOL | 1 | 25% | 0.4% | 5 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000217267 | SURVIVIN//YM155//SURVIVIN EXPRESSION |
| 2 | 0.0000141029 | DRONC//DIAP1//REAPER |
| 3 | 0.0000113466 | APAF 1//CASPASE 2//RAIDD |
| 4 | 0.0000098356 | NECROPTOSIS//RIP3//NECROSTATIN 1 |
| 5 | 0.0000091959 | TRAIL//DR5//TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND |
| 6 | 0.0000081916 | HTRA1//HTRA//HTRA2 |
| 7 | 0.0000076924 | APOPTOSIS INDUCING FACTOR//AIF//AMID |
| 8 | 0.0000076893 | TAK1//TRAF4//TRAF5 |
| 9 | 0.0000075408 | TID1//HRFI//DNAJB1 |
| 10 | 0.0000072098 | CELL DECIS PROC//MATH ARTS SCI//SIGNALING SYST |